Figure 8

(A, B) The top 10 mutant genes were TP53, TTN, FAT1, CDKN2A, MUC16, PIK3CA, CSMD3, NOTCH1, and SYNE1. (C) HNSCC with lower risk scores exhibit more distinct stem cell traits and are less differentiated. (D) TIDE scores were lower in the high-risk group, indicating greater responsiveness to immunotherapy.